sparsentan will reduce the extent or influence of modafinil by impacting hepatic enzyme CYP2C19 metabolism. Use Caution/Check. Sparsentan (a CYP2C19 inducer) decreases publicity of CYP2C19 substrates and cuts down efficacy associated with these substrates. They located that modafinil was a weak inhibtor of the NET and that modafinil’s ability https://modafinil69133.ivasdesign.com/48067542/everything-about-modafinil